209 related articles for article (PubMed ID: 32409195)
41. Low-Dose Computed Tomography Screening in Relatives With a Family History of Lung Cancer.
Wang CL; Hsu KH; Chang YH; Ho CC; Chiang CJ; Chen KC; Cheung YC; Huang PC; Chen YR; Chen CY; Hsu CP; Hsia JY; Chen HY; Yang SY; Li YJ; Yang TY; Tseng JS; Chuang CY; Hsiung CA; Chen YM; Huang MS; Yu CJ; Chen KY; Su WC; Chen JJW; Yu SL; Chen CJ; Yang PC; Tsai YH; Chang GC
J Thorac Oncol; 2023 Nov; 18(11):1492-1503. PubMed ID: 37414358
[TBL] [Abstract][Full Text] [Related]
42. Comparative analysis of 5 lung cancer natural history and screening models that reproduce outcomes of the NLST and PLCO trials.
Meza R; ten Haaf K; Kong CY; Erdogan A; Black WC; Tammemagi MC; Choi SE; Jeon J; Han SS; Munshi V; van Rosmalen J; Pinsky P; McMahon PM; de Koning HJ; Feuer EJ; Hazelton WD; Plevritis SK
Cancer; 2014 Jun; 120(11):1713-24. PubMed ID: 24577803
[TBL] [Abstract][Full Text] [Related]
43. Molecular biomarkers for future screening of lung cancer.
Hensing TA; Salgia R
J Surg Oncol; 2013 Oct; 108(5):327-33. PubMed ID: 23893423
[TBL] [Abstract][Full Text] [Related]
44. Lung Cancer Screening with Low-Dose CT: a Meta-Analysis.
Hoffman RM; Atallah RP; Struble RD; Badgett RG
J Gen Intern Med; 2020 Oct; 35(10):3015-3025. PubMed ID: 32583338
[TBL] [Abstract][Full Text] [Related]
45. Development and Validation of a Multivariable Lung Cancer Risk Prediction Model That Includes Low-Dose Computed Tomography Screening Results: A Secondary Analysis of Data From the National Lung Screening Trial.
Tammemägi MC; Ten Haaf K; Toumazis I; Kong CY; Han SS; Jeon J; Commins J; Riley T; Meza R
JAMA Netw Open; 2019 Mar; 2(3):e190204. PubMed ID: 30821827
[TBL] [Abstract][Full Text] [Related]
46. LDCT lung cancer screening in populations at different risk for lung cancer.
Teles GBDS; Macedo ACS; Chate RC; Valente VAT; Funari MBG; Szarf G
BMJ Open Respir Res; 2020 Feb; 7(1):. PubMed ID: 33371010
[TBL] [Abstract][Full Text] [Related]
47. Factors Associated with a Positive Baseline Screening Exam Result in the National Lung Screening Trial.
Balekian AA; Tanner NT; Fisher JM; Silvestri GA; Gould MK
Ann Am Thorac Soc; 2016 Sep; 13(9):1568-74. PubMed ID: 27387658
[TBL] [Abstract][Full Text] [Related]
48. Low-dose computed tomography screening for lung cancer: results of the first screening round.
Horeweg N; Nackaerts K; Oudkerk M; de Koning HJ
J Comp Eff Res; 2013 Sep; 2(5):433-6. PubMed ID: 24236740
[TBL] [Abstract][Full Text] [Related]
49. Low-dose CT for lung cancer screening: position paper from the Italian college of thoracic radiology.
Silva M; Picozzi G; Sverzellati N; Anglesio S; Bartolucci M; Cavigli E; Deliperi A; Falchini M; Falaschi F; Ghio D; Gollini P; Larici AR; Marchianò AV; Palmucci S; Preda L; Romei C; Tessa C; Rampinelli C; Mascalchi M
Radiol Med; 2022 May; 127(5):543-559. PubMed ID: 35306638
[TBL] [Abstract][Full Text] [Related]
50. Lung Cancer Screening: Survival in an Extensive Early Detection Program in Spain (I-ELCAP).
Cervera Deval J; Barrios Benito M; Peñalver Cuesta JC; Martínez Pérez E; Sandiego Contreras S; Cruz Mojarrieta J; de Aguiar Quevedo K; Arraras Martínez M; Arana E
Arch Bronconeumol; 2022 May; 58(5):406-411. PubMed ID: 35312494
[TBL] [Abstract][Full Text] [Related]
51. Preliminary Results of Lung Cancer Screening in a Socioeconomically Disadvantaged Population.
Guichet PL; Liu BY; Desai B; Surani Z; Cen SY; Lee C
AJR Am J Roentgenol; 2018 Mar; 210(3):489-496. PubMed ID: 29166147
[TBL] [Abstract][Full Text] [Related]
52. Lung cancer screening with low-dose computed tomography: National expenditures and cost-effectiveness.
Zeng X; Zhou Z; Luo X; Liu Q
Front Public Health; 2022; 10():977550. PubMed ID: 36249202
[TBL] [Abstract][Full Text] [Related]
53. Low-dose CT lung cancer screening in never-smokers and smokers: results of an eight-year observational study.
Kakinuma R; Muramatsu Y; Asamura H; Watanabe SI; Kusumoto M; Tsuchida T; Kaneko M; Tsuta K; Maeshima AM; Ishii G; Nagai K; Yamaji T; Matsuda T; Moriyama N
Transl Lung Cancer Res; 2020 Feb; 9(1):10-22. PubMed ID: 32206549
[TBL] [Abstract][Full Text] [Related]
54. Lung cancer screening: a critical appraisal.
Kian W; Zemel M; Levitas D; Alguayn W; Remilah AA; Rahman NA; Peled N
Curr Opin Oncol; 2022 Jan; 34(1):36-43. PubMed ID: 34652284
[TBL] [Abstract][Full Text] [Related]
55. A randomized study of lung cancer screening with spiral computed tomography: three-year results from the DANTE trial.
Infante M; Cavuto S; Lutman FR; Brambilla G; Chiesa G; Ceresoli G; Passera E; Angeli E; Chiarenza M; Aranzulla G; Cariboni U; Errico V; Inzirillo F; Bottoni E; Voulaz E; Alloisio M; Destro A; Roncalli M; Santoro A; Ravasi G;
Am J Respir Crit Care Med; 2009 Sep; 180(5):445-53. PubMed ID: 19520905
[TBL] [Abstract][Full Text] [Related]
56. Assessment of lung cancer mortality reduction after chest X-ray screening in smokers: a population-based cohort study in Varese, Italy.
Dominioni L; Poli A; Mantovani W; Pisani S; Rotolo N; Paolucci M; Sessa F; Conti V; D'Ambrosio V; Paddeu A; Imperatori A
Lung Cancer; 2013 Apr; 80(1):50-4. PubMed ID: 23294502
[TBL] [Abstract][Full Text] [Related]
57. Performance of lung cancer screening with low-dose CT in Gejiu, Yunnan: A population-based, screening cohort study.
Wei MN; Su Z; Wang JN; Gonzalez Mendez MJ; Yu XY; Liang H; Zhou QH; Fan YG; Qiao YL
Thorac Cancer; 2020 May; 11(5):1224-1232. PubMed ID: 32196998
[TBL] [Abstract][Full Text] [Related]
58. Cost-Effectiveness Analysis of Lung Cancer Screening in the United States: A Comparative Modeling Study.
Criss SD; Cao P; Bastani M; Ten Haaf K; Chen Y; Sheehan DF; Blom EF; Toumazis I; Jeon J; de Koning HJ; Plevritis SK; Meza R; Kong CY
Ann Intern Med; 2019 Dec; 171(11):796-804. PubMed ID: 31683314
[TBL] [Abstract][Full Text] [Related]
59. Airflow Limitation and Histology Shift in the National Lung Screening Trial. The NLST-ACRIN Cohort Substudy.
Young RP; Duan F; Chiles C; Hopkins RJ; Gamble GD; Greco EM; Gatsonis C; Aberle D
Am J Respir Crit Care Med; 2015 Nov; 192(9):1060-7. PubMed ID: 26199983
[TBL] [Abstract][Full Text] [Related]
60. Baseline results of the Depiscan study: a French randomized pilot trial of lung cancer screening comparing low dose CT scan (LDCT) and chest X-ray (CXR).
Blanchon T; Bréchot JM; Grenier PA; Ferretti GR; Lemarié E; Milleron B; Chagué D; Laurent F; Martinet Y; Beigelman-Aubry C; Blanchon F; Revel MP; Friard S; Rémy-Jardin M; Vasile M; Santelmo N; Lecalier A; Lefébure P; Moro-Sibilot D; Breton JL; Carette MF; Brambilla C; Fournel F; Kieffer A; Frija G; Flahault A;
Lung Cancer; 2007 Oct; 58(1):50-8. PubMed ID: 17624475
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
